Midday and nadir salivary cortisol appear superior to cortisol awakening response in burnout assessment and monitoringSCIENTIFIC REPORTSIF3.92018-06-1415OAAI
Association between improved liver function and selenium depends on C718T polymorphism in 3′-untranslated region of glutathione peroxidase 4 and in humansJOURNAL OF HEPATOLOGYIF332017-01-010PREAI
A prospective study to evaluate the efficacy of a standardized low calorie diet according to PNPLA3 genotype in patients with Non Alcoholic Fatty Liver Disease (NAFLD)-2 months data (interim analysis)JOURNAL OF HEPATOLOGYIF332017-01-010PREAI
Successful anti-viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis CALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72015-01-2334OAAI
Review article: genetic factors that modify the outcome of viral hepatitisALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72014-03-2455OA
Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis CALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72013-11-1057OAAI
Durability of SVR in chronic hepatitis C patients treated with peginterferon-2a/ribavirin in combination with a direct-acting anti-viralALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72013-05-2628OA
INFLUENCE OF GENDER, AGE AND ITPA POLYMORPHISM (rs6051702, rs1127354, rs7270101) ON THROMBOCYTOPENIA IN HCV GENOTYPE 1 AND 4 PATIENTS ON ANTIVIRAL THERAPYJOURNAL OF HEPATOLOGYIF332013-04-010OAAI
SUCCESSFUL HCV ERADICATION DUE TO ANTIVIRAL THERAPY IS ASSOCIATED WITH IMPROVED LONG TERM OUTCOME OF PATIENTS WITH CHRONIC HEPATITIS CJOURNAL OF HEPATOLOGYIF332013-04-014OAAI
The risk of infections in HIV-HCV coinfected patients during antiviral therapy with pegIFN+RBVJOURNAL OF INFECTIONIF11.92012-08-019PREAI
HAS PEG-IFN-α INDUCED SEVERE THROMBOCYTOPENIA WORSE PLATELET FUNCTION THEN LIVER CIRRHOSIS OR CYTOSTATIC CHEMOTHERAPY INDUCED THROMBOCYTOPENIA?JOURNAL OF HEPATOLOGYIF332012-04-010PREAI
Serum Level of IP-10 Increases Predictive Value of IL28B Polymorphisms for Spontaneous Clearance of Acute HCV InfectionGASTROENTEROLOGYIF25.12012-01-0180OA
Treatment of chronic hepatitis C genotype 1 patients at an academic center in europe involved in prospective, controlled trials: Is there a selection bias?HEPATOLOGYIF15.82012-01-0120PREAI
Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-Naive Patients With Chronic Hepatitis CCLINICAL GASTROENTEROLOGY AND HEPATOLOGYIF122011-04-01150OA
BASELINE VITAMIN D LEVELS DO NOT INFLUENCE SVR IN PATIENTS WITH CHRONIC HCV GENOTYPE 1 OR 4 INFECTION UNDERGOING PEGINTERFERON/RIBAVIRIN TREATMENTJOURNAL OF HEPATOLOGYIF332011-03-016OAAI
Silibinin monotherapy prevents graft infection after orthotopic liver transplantation in a patient with chronic hepatitis CJOURNAL OF HEPATOLOGYIF332011-03-0141OAAI
EFFECTS OF SNP RS6051702 POLYMORPHISM ON ANEMIA AND TREATMENT OUTCOME IN CHRONIC HEPATITIS C GENOTYPE 1 PATIENTSJOURNAL OF HEPATOLOGYIF332011-03-010PREAI
COMBINATION OF IL28 RS12979860 GENOTYPE WITH PRETREATMENT SERUM IP-10 LEVELS IS THE BEST PREDICTOR OF SVR TO PEGINTERFERON/RIBAVIRIN THERAPY IN CHRONIC HEPATITIS C, GT1 PATIENTSJOURNAL OF HEPATOLOGYIF332011-03-010PRE
WEEK 8 HCV-RNA IS THE OPTIMAL PREDICTOR OF RELAPSE IN NON-RVR PATIENTS WITH GENOTYPE 1/4 RANDOMISED TO 48 OR 72 WEEKS PEG-IFN ALFA-2A PLUS RBVJOURNAL OF HEPATOLOGYIF332009-04-013PREAI
INTRAVENOUS SILIBININ AS RESCUE TREATMENT FOR ON TREATMENT NONRESPONDERS TO FULL DOSE OF PEGINTERFERON/RIBAVIRIN COMBINATION THERAPYJOURNAL OF HEPATOLOGYIF332009-04-013OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向